OGDHL and neoplasm: Oxyglutarate dehydrogenase (OGDHL), which can encode a rate-limiting Krebs cycle enzyme, is currently the subject of research focusing on neurodevelopmental disorders, tumours, and other related diseases and is thought to be closely associated with highly variable manifestations of neurological and neurodevelopmental disorders [30].